| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-77808SS | |||
| Azide and BSA Free | NBP2-80664 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54626-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB22441-SP | |||
| Carrier Free | MAB22441-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44901 | |||
| Azide and BSA Free | NBP2-34594-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54625-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF6480-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4246-SP | |||
| Carrier Free | FAB4246B-100 | |||
| Carrier Free | FAB4246V-100UG | |||
| Carrier Free | FAB4246U-100UG | |||
| Carrier Free | FAB4246T-100UG | |||
| Carrier Free | FAB4246S-100UG | |||
| Carrier Free | FAB4246R-100UG | |||
| Carrier Free | FAB4246N-100UG | |||
| Carrier Free | FAB4246G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB3934A | |||
| Carrier Free | MAB3934-SP | |||
| Carrier Free | FAB3934V-100UG | |||
| Carrier Free | FAB3934U-100UG | |||
| Carrier Free | FAB3934T-100UG | |||
| Carrier Free | FAB3934S-100UG | |||
| Carrier Free | FAB3934R-100UG | |||
| Carrier Free | FAB3934N-100UG | |||
| Carrier Free | FAB3934G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF2244-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43390-0.025mg | |||
![Immunohistochemistry-Paraffin: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Human spleen tissue section. Granulocytes stained positive for CD66b. IHC-P was performed using a Leica bond autostainer. Standard IHC protocol, ER2 retrieval, primary antibody was used at 1:500 in BSA/TBS. IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Immunohistochemistry-Paraffin-NB100-77808-img0014.jpg "Immunohistochemistry-Paraffin: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Human spleen tissue section. Granulocytes stained positive for CD66b. IHC-P was performed using a Leica bond autostainer. Standard IHC protocol, ER2 retrieval, primary antibody was used at 1:500 in BSA/TBS. IHC-P image submitted by a verified customer review.")
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Human peripheral blood was stained with Mouse IgM isotype control (left panel), Mouse anti-Human CEACAM-8/CD66b clone G10F5 (right panel), followed by APC-conjugated Goat anti-Mouse IgM secondary antibody.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0012.jpg)
![Immunohistochemistry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Staining of CD66b on FFPE section of human liver. Secondary Antibody is A488 goat anti-mouse IgM. CD66b is shown in green and DAPI in blue. Cells exhibit a morphology that correspond to neutrophils with segmented nuclei. The CD66b Ab is highly specific with virtually no background signal. IHC image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Immunohistochemistry-NB100-77808-img0013.jpg)
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Human peripheral blood granulocytes stained with purified G10F5, followed by anti-mouse Igs FITC.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0001.jpg)
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Analysis using the Alexa Fluor (R) 647 conjugate of NB100-77808. Staining of CD66b in human whole blood using anti-CD66b antibody. The primary antibody was used at a dilution of 1:100 and incubated for 25 minutes at 4C. Flow cytometry image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0007.jpg)
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Analysis using the Alexa Fluor(R) 700 conjugate of NB100-77808. Staining of CD66b in human whole blood using anti-CD66b antibody conjugated with Alexa Fluor 700. The primary antibody was used at a dilution of 1:100 and incubated for 25 minutes at 4C. Flow cytometry image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0008.jpg)
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Analysis using the DyLight 405 conjugate of NB100-77808. Staining of CD66b in human PBMCs using anti-CD66b antibody. Flow cytometry image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0009.jpg)
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Analysis using the PE conjugate of NB100-77808. Staining of CD66b in human whole blood using anti-CD66b antibody conjugated with PE. The primary antibody was used at a dilution of 1:100 and incubated for 25 minutes at 4C. Flow cytometry image submitted by a verifed customer review.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0011.jpg)
![Flow Cytometry: CEACAM8/CD66b Antibody (G10F5) [NB100-77808] - Analysis using the FITC conjugate of NB100-77808. Staining of Human peripheral whole blood granulocytes G10F5 FITC.](http://images.novusbio.com/fullsize/CEACAM8-CD66b-Antibody-G10F5-Flow-Cytometry-NB100-77808-img0010.jpg)
![Immunohistochemistry: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Analysis in human lung: Using Anti-CEACAM6 [1H7-4B] (10 ug/ml) developed with DAB-staining procedure. Dark line indicated shows CEACAM6 expression.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-Immunohistochemistry-NBP2-54626-img0003.jpg "Immunohistochemistry: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Analysis in human lung: Using Anti-CEACAM6 [1H7-4B] (10 ug/ml) developed with DAB-staining procedure. Dark line indicated shows CEACAM6 expression.")
![Flow Cytometry: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM6 [1H7-4B] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-Flow-Cytometry-NBP2-54626-img0002.jpg)
![ELISA: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Solid phase was coated with 3 ug/ml Anti-CEA binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM6 [1H7-4B] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-ELISA-NBP2-54626-img0001.jpg)
![Immunoprecipitation: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Human granulocyte lysate: Utilizing 10 ug/ml Anti-CEACAM6 [1H7-4B]. Detection of the sample using 5 ug/ml pAb Anti-CEA followed by HRP-coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-6-CD66c-Antibody-1H7-4B-Immunoprecipitation-NBP2-54626-img0004.jpg)
![Western Blot: CEACAM-6/CD66c Antibody (1H7-4B) [NBP2-54626] - Detection using 10 μg/ml NBP2-54626 followed by HRP-coupled secondary antibody. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/antibody/nbp2-54626_mouse-ceacam6-cd66c-mab-1h7-4b-bsa-free-western-blot-382023125340..jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-CEA31-Immunohistochemistry-Paraffin-NBP2-33012-img0005.jpg "Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).")
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-CEA31-Immunohistochemistry-Paraffin-NBP2-33012-img0003.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Human Colon Carcinoma stained with CEACAM5/CD66e Antibody (CEA31).](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-CEA31-Immunohistochemistry-Paraffin-NBP2-33012-img0004.jpg)
![Immunohistochemistry-Paraffin: CEACAM5/CD66e Antibody (CEA31) [NBP2-33012] - Analysis of CEACAM5/CD66e antibody (CEA31) on Human Colon Carcinoma. Incubation: 1 ug/mL for 30 minutes at room temperature. Image from verified customer review.](http://images.novusbio.com/fullsize/nbp2-33012_mouse-monoclonal-ceacam5-cd66e-antibody-cea31-17720249362620.jpg)
![Western Blot: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Analysis of human granulocyte lysate: Detection using 10 ug/ml Anti-CEACAM5 [5C8C4] followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Western-Blot-NBP2-54625-img0008.jpg "Western Blot: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Analysis of human granulocyte lysate: Detection using 10 ug/ml Anti-CEACAM5 [5C8C4] followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.")
![Flow Cytometry: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM5 [5C8C4] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Flow-Cytometry-NBP2-54625-img0003.jpg)
![ELISA: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Solid phase was coated with 3 ug/ml Anti-CEA (Dako) binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM5/8 [5C8C4] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-ELISA-NBP2-54625-img0002.jpg)
![Immunoprecipitation: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Human granulocyte lysate: Utilizing 10 ug/ml Anti-CEACAM5/8 [5C8C4]. Detection of the sample using 5 ug/ml pAb Anti-CEA followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Immunoprecipitation-NBP2-54625-img0006.jpg)
